MUC20 and pancreatic ductal adenocarcinoma: In contrast, a previous study revealed that MUC20 knockdown decreased MET phosphorylation in pancreatic ductal adenocarcinoma cells [27], suggesting that MUC20 might exert opposite effects on MET phosphorylation depending on the cancer type.